Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

This publication has 38 references indexed in Scilit:

• Safety and Immunogenicity of Env 2-3, a Human Immunodeficiency Virus Type 1 Candidate Vaccine, in Combination with a Novel Adjuvant, MTP-PE/MF59
  AIDS Research and Human Retroviruses, 1996
• Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
  Vaccine, 1996
• Induction of Mucosal Antibodies by Live Attenuated and Inactivated Influenza Virus Vaccines in the Chronically III Elderly
  The Journal of Infectious Diseases, 1996
• Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59
  Vaccine, 1995
• Prophylaxis and Treatment of Influenza
  New England Journal of Medicine, 1990
• Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit
  Vaccine, 1989
• Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination
  Published by American Medical Association (AMA) ,1973
• Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugationPresented by the senior author before the symposium on Influenza Vaccines, London, 27 April 1972.
  Published by Oxford University Press (OUP) ,1973
• Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine
  Published by American Medical Association (AMA) ,1969
• SEROLOGICAL RESPONSE TO INTRANASAL ADMINISTRATION OF INACTIVE INFLUENZA VIRUS IN CHILDREN 1
  Journal of Clinical Investigation, 1947